Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Medical Equipment Industry Analysis

UpdatedMay 03, 2026
DataAggregated Company Financials
Companies10
  • 7D-1.7%
  • 3M-10.5%
  • 1Y-25.6%
  • YTD-11.3%

Over the last 7 days, the Medical Equipment industry has dropped 1.7%, driven by Alcon declining 1.8%. However, the industry is down 26% over the past year. As for the next few years, earnings are expected to grow by 14% per annum.

Industry Valuation and Performance

Has the Swiss Medical Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 03 May 2026CHF 60.8bCHF 17.3bCHF 2.0b32.2x31.1x3.5x
Tue, 31 Mar 2026CHF 61.4bCHF 17.5bCHF 2.0b33.7x31.1x3.5x
Thu, 26 Feb 2026CHF 68.9bCHF 17.2bCHF 1.9b23.5x35.7x4x
Sat, 24 Jan 2026CHF 70.4bCHF 17.1bCHF 2.1b25.3x34x4.1x
Mon, 22 Dec 2025CHF 68.5bCHF 17.2bCHF 2.1b23.6x33x4x
Wed, 19 Nov 2025CHF 65.7bCHF 17.3bCHF 2.1b22.8x31.6x3.8x
Fri, 17 Oct 2025CHF 66.5bCHF 17.0bCHF 2.0b32.8x33.1x3.9x
Sun, 14 Sep 2025CHF 71.0bCHF 17.1bCHF 2.0b33.9x35.3x4.2x
Tue, 12 Aug 2025CHF 74.4bCHF 17.1bCHF 2.1b35x34.6x4.3x
Thu, 10 Jul 2025CHF 75.7bCHF 17.0bCHF 2.1b36.9x35.5x4.5x
Sat, 07 Jun 2025CHF 79.0bCHF 17.2bCHF 2.2b37.2x36.5x4.6x
Mon, 05 May 2025CHF 82.4bCHF 17.0bCHF 2.1b36.4x39.3x4.9x
Wed, 02 Apr 2025CHF 82.8bCHF 17.6bCHF 2.2b36.7x38.4x4.7x
Fri, 28 Feb 2025CHF 88.0bCHF 17.8bCHF 2.2b42.7x40.8x4.9x
Sun, 26 Jan 2025CHF 89.5bCHF 17.8bCHF 2.1b37.9x42x5x
Tue, 24 Dec 2024CHF 82.5bCHF 17.7bCHF 2.1b36.2x38.9x4.7x
Thu, 21 Nov 2024CHF 82.2bCHF 17.5bCHF 2.1b36.3x38.9x4.7x
Sat, 19 Oct 2024CHF 91.3bCHF 17.1bCHF 2.1b42.7x44x5.3x
Mon, 16 Sep 2024CHF 89.6bCHF 16.9bCHF 2.0b44x43.8x5.3x
Wed, 14 Aug 2024CHF 84.6bCHF 16.9bCHF 1.9b43.6x44x5x
Fri, 12 Jul 2024CHF 86.7bCHF 17.2bCHF 2.0b48.5x44.2x5x
Sun, 09 Jun 2024CHF 87.3bCHF 17.2bCHF 2.0b49.4x44.5x5.1x
Tue, 07 May 2024CHF 79.8bCHF 17.2bCHF 1.9b44.8x42x4.6x
Thu, 04 Apr 2024CHF 85.0bCHF 17.2bCHF 1.9b46.7x44.8x4.9x
Sat, 02 Mar 2024CHF 87.1bCHF 17.0bCHF 2.0b43.6x43.9x5.1x
Mon, 29 Jan 2024CHF 80.3bCHF 16.6bCHF 1.6b55.4x48.7x4.8x
Wed, 27 Dec 2023CHF 80.6bCHF 16.5bCHF 1.6b54.6x49x4.9x
Fri, 24 Nov 2023CHF 75.4bCHF 16.9bCHF 1.7b48.9x44.2x4.5x
Sun, 22 Oct 2023CHF 70.8bCHF 16.8bCHF 1.6b45x44x4.2x
Tue, 19 Sep 2023CHF 78.8bCHF 16.8bCHF 1.6b53.9x49.1x4.7x
Thu, 17 Aug 2023CHF 80.0bCHF 16.6bCHF 1.6b56.5x50x4.8x
Sat, 15 Jul 2023CHF 83.0bCHF 16.4bCHF 1.6b53.4x50.5x5.1x
Mon, 12 Jun 2023CHF 79.7bCHF 16.7bCHF 1.7b48.9x48x4.8x
Wed, 10 May 2023CHF 79.3bCHF 16.3bCHF 1.6b50.5x48.7x4.9x
Price to Earnings Ratio

48.7x


Total Market Cap: CHF 79.3bTotal Earnings: CHF 1.6bTotal Revenue: CHF 16.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Medical Equipment Industry Price to Earnings3Y Average 41.1x202420252026
Current Industry PE
  • Investors are pessimistic on the Swiss Medical Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 31.1x which is lower than its 3-year average PE of 41.1x.
  • The 3-year average PS ratio of 4.6x is higher than the industry's current PS ratio of 3.5x.
Past Earnings Growth
  • The earnings for companies in the Medical Equipment industry have grown 6.3% per year over the last three years, while revenues have remained mostly flat.
  • This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market-0.28%
Healthcare0.056%
Medical Equipment-1.67%
Medical Equipment-1.36%
Medical Supplies-1.94%
Industry PE
  • Investors are most optimistic about the Medical Supplies industry even though it's trading below its 3-year average PE ratio of 54.6x.
    • Analysts are expecting annual earnings growth of 13.2%, which is higher than its past year's earnings decline of 6.8% per year.
  • Investors are most pessimistic about the Medical Equipment industry, which is trading below its 3-year average of 35.9x.
Forecasted Growth
  • Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 16% over the next 5 years.
  • This is better than its past earnings growth rate of 12% per year.
  • In contrast, the Medical Supplies industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
VBSN IVF Hartmann HoldingCHF 135.002.3%
+CHF 7.1m		-10.3%PE17.6x
METN Metall ZugCHF 725.000.3%
+CHF 893.4k		-31.0%PS1.7x

Latest News

ALC
CHF 58.22
Alcon
7D
-1.8%
1Y
-28.3%
YPSN
CHF 273.00
Ypsomed Holding
7D
-3.0%
1Y
-23.1%

YPSN: Share Buyback And Recent Upgrade Will Support Long Term Upside

Analysts have slightly adjusted their view on Ypsomed Holding, trimming the fair value estimate from CHF 314.70 to CHF 309.85 as they factor in updated assumptions for discount rates, revenue growth, profit margins and future P/E, reflected in part by a recent upgrade from Barclays. Analyst Commentary Even with the fair value estimate only slightly adjusted, some readers may want to pay close attention to where analysts see potential pressure on the story, especially around valuation and execution against expectations.
STMN
CHF 84.50
Straumann Holding
7D
-0.02%
1Y
-19.1%

STMN: Higher Future P/E Assumptions Will Support Confidence In Execution Potential

Straumann's updated analyst price target holds around CHF 123, with recent small CHF 1 to CHF 3 adjustments from different banks reflecting analysts' mixed views on future growth, profit margins, and the appropriate P/E level for the shares. Analyst Commentary Recent Street research shows a mix of views on Straumann, with price targets clustering around CHF 79 to CHF 123 and opinions split on whether the current P/E is justified.
MOVE
CHF 141.60
Medacta Group
7D
-4.5%
1Y
0.1%
MEDX
CHF 8.32
medmix
7D
-3.7%
1Y
-21.2%

MEDX: Stable Dividend And Consistent Assumptions Will Support Future Upside Potential

Analysts now place the medmix price target at CHF 15.97, with the updated view largely grounded in refreshed assumptions for the discount rate, revenue growth, profit margin and future P/E that remain closely aligned with prior expectations. What's in the News medmix AG set an annual dividend of CHF 0.10 per share, with payment scheduled for April 22, 2026 (Key Developments).
MED
CHF 76.90
Medartis Holding
7D
-0.1%
1Y
1.3%

MED: Slightly Higher Margins And Stable Outlook Will Support Future Upside

Analysts have kept their CHF price target for Medartis Holding broadly unchanged near CHF 96, citing slightly higher assumed revenue growth, a modestly stronger profit margin, and a marginally lower future P/E multiple in their refreshed models. Valuation Changes Fair Value: CHF 95.97 is unchanged in the refreshed model.
SOON
CHF 171.20
Sonova Holding
7D
-2.3%
1Y
-33.4%

SOON: Portfolio Shift And Execution Improvements Will Support Medium Term Upside

Analysts have trimmed their average price target on Sonova Holding by CHF 6, reflecting slightly adjusted fair value assumptions and a lower future P/E multiple, following a mix of recent target cuts and rating changes across the Street. Analyst Commentary Recent research shows a split tape, with several target cuts balanced by fresh upgrades that highlight where bullish analysts see room for upside if execution stays on track.
CLTN
CHF 46.60
COLTENE Holding
7D
-4.2%
1Y
-26.1%
METN
CHF 725.00
Metall Zug
7D
0.3%
1Y
-31.0%
VBSN
CHF 135.00
IVF Hartmann Holding
7D
2.3%
1Y
-10.3%